HomeCTXR • NASDAQ
add
Citius Pharmaceuticals Inc
Previous close
$0.78
Day range
$0.76 - $0.80
Year range
$0.63 - $4.51
Market cap
16.19M USD
Avg Volume
1.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.44M | -23.65% |
Net income | -7.96M | 26.24% |
Net profit margin | — | — |
Earnings per share | -0.11 | 98.10% |
EBITDA | -8.44M | 23.65% |
Effective tax rate | -3.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.25M | 30.76% |
Total assets | 130.94M | 12.25% |
Total liabilities | 53.41M | 25.52% |
Total equity | 77.53M | — |
Shares outstanding | 20.76M | — |
Price to book | 0.21 | — |
Return on assets | -16.31% | — |
Return on capital | -28.35% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.96M | 26.24% |
Cash from operations | -11.88M | -100.94% |
Cash from investing | -5.75M | -15.00% |
Cash from financing | 15.79M | 521.55% |
Net change in cash | -1.84M | 87.47% |
Free cash flow | -20.17M | -193.49% |
About
Founded
2007
Headquarters
Website
Employees
23
